BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation. J Arrhythm 2021;37:1389-426. [PMID: 34887945 DOI: 10.1002/joa3.12652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Jung M, Byeon K, Kang KW, Park YM, Hwang YM, Lee SH, Jin ES, Roh SY, Kim JS, Ahn J, Lee SR, Choi EK, Ahn MS, Lee EM, Park HC, Lee KH, Kim M, Choi JH, Ko JS, Kim JB, Kim C, Lip GYH, Shin SY; Clinical Survey on Stroke Prevention in Patients with Atrial Fibrillation (CS-SPAF) Investigators. Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA2DS2-VASc Score 0-1: A Korean Multi-Center Cohort. Yonsei Med J 2022;63:892-901. [PMID: 36168241 DOI: 10.3349/ymj.2022.0157] [Reference Citation Analysis]
2 Shen X, Liao J, Jiang Y, Xu Y, Liu M, Zhang X, Dong N, Yu L, Chen Q, Fang Q. Elevated NT-proBNP levels are associated with CTP ischemic volume and 90-day functional outcomes in acute ischemic stroke: a retrospective cohort study. BMC Cardiovasc Disord 2022;22:431. [PMID: 36180827 DOI: 10.1186/s12872-022-02861-w] [Reference Citation Analysis]
3 Wang R, Ning N, Wang S, Ye X, Hu X, Xuan J. Real-world treatment patterns and stroke risks among patients with atrial fibrillation in China. Future Cardiol 2022;18:787-96. [PMID: 36154219 DOI: 10.2217/fca-2022-0050] [Reference Citation Analysis]
4 Liao J, Chan Y, Kuo L, Tsai C, Lim S, Chao T. Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.874460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chao TF, Tse HF, Teo WS, Park HW, Shimizu W, Chen SA, Lip GYH; Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. Eur J Clin Invest 2022;:e13825. [PMID: 35700114 DOI: 10.1111/eci.13825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 O UF, Chong TK, Wei Y, Paudel B, Giudici MC, Wong CW, Lei WK, Chen J, Wu W, Liu K. Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants. IJC Heart & Vasculature 2022;40:101009. [DOI: 10.1016/j.ijcha.2022.101009] [Reference Citation Analysis]
7 Yeh Y, Chan Y, Chen S, Chang S, Wang C, Kuo C, Li GY, Chen S, Chao T. Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia. The American Journal of Medicine 2022. [DOI: 10.1016/j.amjmed.2022.03.011] [Reference Citation Analysis]
8 Liao J, Kuo L, Liu C, Chen S, Chao T. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with advanced chronic kidney and liver diseases. European Heart Journal Supplements 2022;24:A11-8. [DOI: 10.1093/eurheartj/suab154] [Reference Citation Analysis]